James Garner
Family Medicine · Mullins, SCNPI 1215900675
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 296 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,426 and has fallen 69.1% since, to $440 in 2022.
Across 296 payments — averaging $13.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$528
- AstraZeneca$437
- AbbVie$435
- Novo Nordisk$267
- Merck$267
- Amarin Pharma, Inc.$230
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,043100%
- Education$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 38 | $528 |
| AstraZeneca | 30 | $437 |
| AbbVie(2 entities) | 49 | $435 |
| Novo Nordisk | 19 | $267 |
| Merck | 20 | $267 |
| Amarin Pharma, Inc. | 16 | $230 |
| Pfizer | 14 | $222 |
| Astellas Pharma US Inc | 15 | $217 |
| Novartis | 12 | $196 |
| Johnson & Johnson | 12 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $181 |
| Lilly USA, LLC | 11 | $141 |
| Sanofi-aventis U.S. LLC | 7 | $103 |
| GSK | 5 | $82 |
| Amgen | 6 | $76 |
| Esperion Therapeutics, Inc. | 5 | $76 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $68 |
| Mylan Specialty L.p. | 3 | $62 |
| Kowa Pharmaceuticals America, Inc. | 5 | $62 |
| Alkermes, Inc. | 2 | $45 |
| Medicure Pharma Inc. | 1 | $39 |
| Biohaven Pharmaceuticals, Inc. | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Abbott | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $13 |
How this compares
$4,043 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Mullins
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
- Scott SmithMount Pleasant$68K
- Jennifer StolinSummerville$59K
- Nicholas PenningsNorth Myrtle Beach$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.